Stock Comparison
ABBV vs MRK
AbbVie Inc and Merck & Company Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$328.21B
P/E (TTM)
70.3
106.5
Forward P/E
17.7
48.4
Price/Sales
6.8
5.0
Price/Book
51.1
7.2
EV/EBITDA
25.8
50.4
Dividend Yield
2.03%
2.48%
Profitability
Net Margin
9.82%
13.62%
Operating Margin
29.77%
27.59%
Return on Equity
62.30%
18.90%
Return on Assets
10.50%
12.60%
Growth (YoY)
Revenue Growth
10.20%
5.10%
Earnings Growth
290.40%
-19.30%
Price & Risk
Beta
0.3
0.2
52-Week High
$263.65
$135.57
52-Week Low
$197.38
$76.39
Analyst Target
$274.36
$136.65
Compare ABBV and MRK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.